Medicare May Scale Back Coverage Restrictions For Alzheimer’s Drugs; Will It Be Enough?
Even if the final Medicare national coverage decision switches to a registry, Aduhelm access will still be too limited, patient advocates worry, prompting them to ‘move the conversation’ to Congress for relief. Prospects for a new Republican majority in the House could help.
